Natural and antibody-dependent cellular cytotoxicity in chronic myeloid leukemia patients in remission.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0145-2126(86)90043-3PMID 3456474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer

  2005cited by this paper
• Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.

  1984cited by this paper
• Natural killer‐interferon system in patients with preleukaemic states

  1984cited by this paper
• PHA-ICC, ADCC and NK in patients with ANLL in CR: human fibroblastic interferon fails to increase NK-active cell frequency.

  1984cited by this paper
• Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.

  1984cited by this paper
• Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome.

  1984cited by this paper
• Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies.

  1984cited by this paper
• Peripheral k‐lymphocyte population in head and neck cancer

  1984cited by this paper
• Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.

  1984cited by this paper
• Human breast cancer and impaired NK cell function

  1983cited by this paper
• Suppressor cells of natural killer activity in normal and tumor-bearing individuals.

  1983cited by this paper
• Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.

  1983cited by this paper
• Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.

  1983cited by this paper
• Natural killer activity and low-affinity E rosettes in acute leukemias.

  1983cited by this paper
• Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes.

  1983cited by this paper
• Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.

  1983cited by this paper
• Normalized natural killer (NK) cell activity in long‐term remission of acute leukaemia

  1983cited by this paper
• Circulating immune complexes in chronic myeloid leukemia patients at various stages of the disease.

  1983cited by this paper
• Immunologic evaluation of long‐term effects of childhood all chemotherapy: Analysis of in vitro NK‐ and K‐cell activities of peripheral blood lymphocytes

  1982cited by this paper
• Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remission

  1982cited by this paper
• Depressed natural killer cell activity in patients with hepatocellular carcinoma in vitro effects of interferon and levamisole

  1982cited by this paper
• Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia.

  1982cited by this paper
• Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.

  1982cited by this paper
• Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.

  1981cited by this paper
• Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.

  1981cited by this paper
• In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.

  1981cited by this paper
• Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.

  1980cited by this paper
• Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.

  1979cited by this paper
• Normal antibody-dependent killer cell function in patients with chronic lymphocytic leukemia.

  1977cited by this paper
• Separation of leukocytes from blood and bone marrow. Introduction.

  1968cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood.

  1968cited by this paper

• CML presenting synchronously with squamous cell carcinoma of cervix: A case report

  2019cites this paper
• Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia

  2005influential citation
• In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission

  2004cites this paper
• Innovative therapy for chronic myelogenous leukemia.

  1998cites this paper
• The role of autologous natural killer cells in chronic myelogenous leukemia.

  1997cites this paper
• Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.

  1996cites this paper
• Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2

  1992cites this paper
• Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

  1990cites this paper
• Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.

  1990cites this paper
• [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].

  1990cites this paper
• Studies on natural killer cells in chronic myeloid leukemia patients in remission.

  1990cites this paper
• Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.

  1990cites this paper
• Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.

  1989cites this paper
• Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.

  1989cites this paper
• Cell-mediated cytotoxicity in children during and after therapy for acute lymphoblastic leukemia.

  1988cites this paper
• Functional & phenotypic studies on leukaemic T cells from acute lymphoblastic leukaemia.

  1988cites this paper